Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
BASEL, Switzerland and LONDON and NEW YORK, Feb. 13, 2024 Roivant today reported its financial results for the third quarter ended December 31, 2023, and provided a business update. Roivant.
Incident prescriptions dispensed for 5 drug classes used to treat depression, anxiety, ADHD, and opioid use disorder, was assessed before and during the COVID-19 pandemic.